The following section provides information on Pharming Group NV’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Pharming Group NV's management and employees, unlock the full data with our company analytics monitoring tool.
Mr. Paul Sekhri has been the Chairman of the company since October 2008. Prior to this, served as the President and Chief Executive Officer of Lycera Corp. Previously, he served as the Senior Vice President, Integrated Care at Sanofi; Group Executive Vice President, Global Business Development and Chief Strategy Officer for Teva Pharmaceutical Industries Ltd.
Mr. Sijmen de Vries has been the Director and the Chief Executive Officer of Pharming Group NV since 2016. Prior to this, he served as the Chief Executive Officer of 4-Antibody and Morphochem AG. Mr. Vries also held senior business and management positions at Novartis, Novartis Ophthalmics and SmithKline Beecham Pharmaceuticals.
Mr. Jeroen Wakkerman has been the Chief Financial Officer of the company since November 2020. Prior to this role, he served as the Chief Financial Officer of Nutreco N.V. and SHV Energy NV. Mr. Wakkerman also served as the Finance Director at Calor Gas (UK) and has held several financial and commercial positions at Unilever and Rabobank.
Ms. Mireille Sanders has been the Chief Operating Officer of the company since December 2020. Prior to this, she served as the Senior Vice President, Operations of the company. Ms. Sanders also served as the Head of Clinical Supply Chain Strategic Management and Systems at Janssen Pharmaceuticals. Prior to Janssen, she held senior positions at Merck.
Mr. Anurag Relan has been the Chief Medical Officer of the company since 2021. Previously he served as Vice President, Clinical Research and Medical Affairs at Pharming.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer